Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Protein Sciences, Texas A&M combine intellectual property positions on BEVS

Feb. 24, 1999

Anesta enters agreement with Novartis for transmucosal drug delivery

Feb. 24, 1999

DiagnoCure plans preclinical trials of its patented vectors in melanoma

Feb. 24, 1999

Trimera mouse model for human HBV described

Feb. 23, 1999

Xenometrix grants gene expression profiling patent license to Genzyme

Feb. 23, 1999

U.S. patent providing improved gene delivery vectors issued to GenVec

Feb. 22, 1999

Incyte and ICAgen collaborate on ion channel R&D

Feb. 19, 1999

Inhale branches out into pulmonary controlled release

Feb. 18, 1999

Proteomics research grant awarded to Kinetek

Feb. 18, 1999

Apotex extends agreement with Cangene

Feb. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...